Martin Louis Wilson - General Counsel at ROCKET PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Issuer Symbol
RCKT, RCKTW on Nasdaq
All Insider Reports
All Insider Reports

Martin Louis Wilson - trading volume in the past year for ROCKET PHARMACEUTICALS, INC.

Holdings reported by Martin Louis Wilson for ROCKET PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 682,000 $2,276,516 $3.34 18 Feb 2026 Direct
Stock Option (Right to Buy) 468,187 $2,025,016 $15.04 11 Feb 2026 Direct Common Stock

Transactions reported by Martin Louis Wilson for ROCKET PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.